TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results…
NextGenInnov8 Announces Publication of Case Study on Young Innovator Aditya Pachpande, Aligned with India’s Push for STEM and Innovation Education
PUNE, India, Feb. 18, 2025 /PRNewswire/ -- NextGenInnov8, a forward-thinking organization fostering…
Cisco Study: CEOs Embrace AI, But Knowledge Gaps Threaten Strategic Decisions and Growth
97% of CEOs plan AI integration, but only 1.7% feel fully prepared.…
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program
February 08, 2025 14:30 ET | Source: 4D Molecular Therapeutics, Inc. 3E10…
IBM Study: Gen AI Will Elevate Financial Performance of Banks in 2025
Initiatives are maturing from pilots and proofs of concept to targeted, enterprise-wide…
Axtria Harnesses GenAI to Slash Timelines and Boost Accuracy in Clinical Study Reporting with Axtria Rapid CSR
GenAI-powered solution delivers clinical study reports in minutes with 30%–50% faster turnarounds,…
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Investigational Review Board (IRB) approval has been granted for the open-label study…
First Breakthrough Study Highlights Superiority of MatriDerm in Wound Healing
MatriDerm® by MedSkin Solutions Dr. Suwelack AG Proven to Enhance Cell Activity,…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
First Breakthrough Study Highlights Superiority of MatriDerm in Wound Healing
MatriDerm® by MedSkin Solutions Dr. Suwelack AG Proven to Enhance Cell Activity,…